Literature DB >> 25627461

Difference in inflammatory cytokine production by mononuclear cells from obese and non-obese schizophrenic patients.

P Sirota1,2, E Hadi1, M Djaldetti2,3, H Bessler2,3.   

Abstract

OBJECTIVE: Schizophrenic patients have an increased risk for obesity compared with the general population. Evidence suggests the existence of an inflammatory process in the etiology of both obesity and schizophrenia. Our study compares in vitro secretion of inflammatory cytokines by peripheral blood mononuclear cells (PBMC) obtained from obese and non-obese schizophrenic patients.
METHOD: Mononuclear cells were isolated from 20 obese (BMI >27) and 20 non-obese (BMI <24) schizophrenic in-patients. The levels of TNF-α, IL-1β, IL-6, IL-1ra, IL-10 or IL-2 and IFN-γ in the supernatants of stimulated PBMC, as well as leptin and adiponectin serum values were evaluated.
RESULTS: Peripheral blood mononuclear cells from patients in the obese group showed a significantly increased TNF-α and IL-1β production, whereas the release of IL-1ra was decreased as compared with the non-obese group. In the obese group, the serum concentration of leptin was significantly higher and that of adiponectin was significantly lower. The results of the remaining cytokines did not differ between the two groups.
CONCLUSION: Our study indicates the existence of a difference between obese and non-obese schizophrenic subjects as for inflammatory cytokine production and serum leptin and adiponectin levels, suggesting a 'subclinical inflammatory state' in obese schizophrenic patients that may contribute to a predisposition to inflammation and infections.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  inflammatory cytokines; obesity; peripheral blood mononuclear cells; schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25627461     DOI: 10.1111/acps.12396

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

Review 1.  Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications.

Authors:  Trehani M Fonseka; Daniel J Müller; Sidney H Kennedy
Journal:  Mol Neuropsychiatry       Date:  2016-01-08

2.  Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics.

Authors:  Xinyu Fang; Yewei Wang; Yan Chen; Juanjuan Ren; Chen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-29       Impact factor: 2.570

3.  Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy.

Authors:  Xinyu Fang; Lingfang Yu; Dandan Wang; Yan Chen; Yewei Wang; Zenan Wu; Ruimei Liu; Juanjuan Ren; Wei Tang; Chen Zhang
Journal:  Front Psychiatry       Date:  2020-11-25       Impact factor: 4.157

4.  History of Suicide Attempts and COVID-19 Infection in Veterans with Schizophrenia or Schizoaffective Disorder: Moderating Effects of Age and Body Mass Index.

Authors:  Olaoluwa O Okusaga; Rachel L Kember; Gina M Peloso; Roseann E Peterson; Mariana Vujkovic; Brian G Mitchell; Jared Bernard; Annette Walder; Tim B Bigdeli
Journal:  Complex Psychiatry       Date:  2021-12-01

5.  Prospective cohort study of the evaluation of patient benefit from the redevelopment of a complete national forensic mental health service: the Dundrum Forensic Redevelopment Evaluation Study (D-FOREST) protocol.

Authors:  Mary Davoren; Ken O'Reilly; Damian Mohan; Harry G Kennedy
Journal:  BMJ Open       Date:  2022-07-22       Impact factor: 3.006

6.  Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis.

Authors:  Bruno Romeo; Marine Brunet-Lecomte; Catherine Martelli; Amine Benyamina
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

7.  Plasmacytoid dendritic cell and myeloid dendritic cell function in ageing: A comparison between elderly and young adult women.

Authors:  Marloes van Splunter; Olaf Perdijk; Henriëtte Fick-Brinkhof; Esther G Floris-Vollenbroek; Ben Meijer; Sylvia Brugman; Huub F J Savelkoul; Els van Hoffen; R J Joost van Neerven
Journal:  PLoS One       Date:  2019-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.